Strategic P&L responsibility or the CRO division within DB - Eur 600m. Responsibilities included:- Supported Business cost savings initiatives by achieving cost targets and tracking performance through periodic variance analysis- Identification of risk and opportunities for better financial planning- Evaluation of Change Management proposals for cost reductions - Strategic Planning for the business - worked with Senior Management to align on bank strategies

Responsibilities included -- Review and analysis of all Pillar 1 metrics including RWA and Leverage including presentation of Total Capital Demand (TCD) numbers to senior management covering Investment Banking, Transaction Banking and Private Banking Products- Change initiatives for RWA optimization - data related clean ups for Central Counterparties and LGD corrections, Modelled and Unmodelled trades, Settlement risk- Faceoffs with audits - Internal and External including regulatory audits (ECB)- • Led Risk Data Control Transformation initiatives contributing to the implementation of a single data warehouse for Risk and Finance

Legal Entity reporting and control of all IB products including Global Markets, GTB and Retail Banking. Strategic implementations of reporting platforms including back end support for roll outs.

Responsible for FP&A and GL for J&J Medical Asia-Pacific for key strategic divisions - Regional Planning and Supply Chain , Vistakon and R&D divisions

FP&A responsibility for Ultrasound division for EMEA region. Managed a P&L size of USD 200m with focus on Sales to Margin